Field trial of combined yellow fever and measles vaccines among children in Nigeria

East African Medical Journal

Volumn 73, Issue 9, 1996, Pages 579-582

  Adu, F D ^b   Omotade, O O ^c   Oyedele, O I ^c   Ikusika, O ^c   Odemuyiwa, S O ^c   Onoja, A L ^a  

^a Federal Yellow Fever Production   (Nigeria)

^b UNIVERSITY OF IBADAN   (Nigeria)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

MEASLES VACCINE; YELLOW FEVER VACCINE;

AGE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG TOLERABILITY; FEMALE; HUMAN; IMMUNOGENICITY; INFANT; MAJOR CLINICAL STUDY; MALE; MEASLES; NIGERIA; VACCINATION; YELLOW FEVER;

AGE FACTORS; FEVER; HUMANS; IMMUNIZATION SCHEDULE; INFANT; MEASLES VACCINE; NIGERIA; VACCINES, COMBINED; VIRAL VACCINES; YELLOW FEVER VIRUS;

EID: 0030424165     PISSN: 0012835X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Tomori, O. and Nasidi, A. Yellow fever in Nigeria 1913-1987. Federal Ministry of Health Publication. Federal Ministry of Health; Federal Secretariat, Ikoyi Lagos, 1988; pp60.
2. DeCock, K.M., Monath, T.P., Nasidi A. and Tukei, P.M. et al. Epidemic yellow fever in eastern Nigeria. Lancet, 1986; 35:630-633.
3. Nasidi, A., Monath, T.P., DeCock, K., Tomori, O. and Cordelier, R. et al. Urban yellow fever epidemics in western Nigeria 1987. Trans. roy. soc. trop. Med. Hyg. 1989; 83:
4. Monath, T.P. Yellow fever in Nigeria: Summary of past,present and possible future status. Cat ORSTOM Ser Ent.Med.et Parasitol. X; 169-175.
5. Causey, O.R. and Kemp, G.E. Surveillance and study of viral infections of vertebrates in Nigeria. Nig. J. Sci. 1968; 2:131-135.
6. Nakano, J.H., Miller, D.L., Foster, O.S. and Brink, W.E. Microtitre determination of measles heamagglutination antibody with filter paper. J.Clin.Microbiol. 1983; 17:860-863.
7. Whittle, H.C., Rowland, M.G.M., Mann, G.F., Lamb, W.H. and Lewis, R.A. Immunisation of 4-6 month old Gambian infants with Edmonson Zagreb measles vaccine.Lancet. 1984; 2:834-837.
8. Norby, E. Heamagglutination by measles virus: A simple procedure for production of high potency antigen for heamagglutination inhibition test. Pro.Soc.Exp.Biol.Med. 1962; 3:814-818.
9. Nogueira, R.M.R., Schatzmayr, H.G., Miagostovich, M.P., Cavalcanti, S.M.B. and De Carvalho, R. Use of MAC-ELISA for evaluation of yellow fever vaccination. Rev. Inst.Med.Trop.Sao Paulo. 1992; 34:447-450.
10. Osinusi, K., Akinkugbe, F.M., Akinwolere, O.A. and Fabiyi, A. Safety and efficacy of yellow fever vaccine in children less than one year old. West Afr. J. Med. 1990; 9:200-203.
11. Mouchon, D., Pignon, D., Vicons, R., Tu-Ha Thanh, Tekaia, F., Teulieres, L. and Garrigue, G. The combined yellow fever and measles vaccination in African infants aged 6 to 10 months. Bull. Soc. Pathol. Exol. Filiales. 1990; 83:537.
12. Lhuillier, M., Mazzariol, M.J. Zadi, S. and Le-Cam N. et al.study of combined vaccination against yellow fever and measles in infants from six to nine months. J. Biol. Stand. 1989; 17:9-15.